Genen Pharmaceuticals Co., Ltd, a subsidiary of Genen International Group, whose business covers pharmaceuticals and new energy, is a specialized manufacturer and supplier of advanced and key pharmaceutical intermediates and relevant API mainly for oncology and anti-cancer use. With own standard lab, pilot plant and industrialization base, we made plenty of investment into R&D every year. Our core R&D team is made up of quite a few of doctors and engineers with great pharmaceutical background and rich experiences, which ensures the company to provide the customers with high quality products and services. Besides, we have sales office in Hongkong, Shenzhen and other big cities to better serve customers.

With advanced production process, we implement strict QC procedure and conduct inspection to all the products strictly according to regulations under related pharmacopoeia and ICH to make sure that the quality meets the customers' requirements. Our main products, including bortezomib, bortezomib intermediates, elinogrel, olaparib, crizotinib and other API, are widely used in reagent production and research fields like cell pharmaceutical theory and molecular biology. Besides, we also supply a range of domestically made API, most of which are from GMP certified manufacturers and some have already been certified by FDA.

Since foundation, our products have been exported to USA, Europe, India and other countries and are well recognized by the customers.
With quality-oriented tenet, Genen would stand out on the market with favorable price and excellent service and we would do all the best to achieve a win-win result with the customers.